EWTX logo

Edgewise Therapeutics, Inc. (EWTX)

Profile

Full Name

Edgewise Therapeutics, Inc.

Ticker

NASDAQ: EWTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 26, 2021

Indexes

Not included

Website

https://edgewisetx.com

Employees

117

Key Details

Price

$14.06(+2.63%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.45(+7.64% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.06
    EWTX price is $14.06

    30-Day Relative Volume

    1.06
    EWTX 30-day relative volume is 1.06

    Price Performance

    Price Most recent change

    +2.63%
    EWTX price was up +2.63% on Sep 16, 2025

    Price YTD change

    -47.34%
    EWTX price is down -47.34% since January 1st

    Price 1-year change

    -16.61%
    EWTX price is down -16.61% year-on-year

    Price 3-year change

    +46.76%
    EWTX price is up +46.76% over the past 3 years

    Price Range

    Price All-time high

    $40.49
    EWTX price is currently -65.28% below its historical high of $40.49

    Price 3-year low

    $5.12
    EWTX price is currently +174.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.48B
    EWTX market capitalization is $1.48 billion

    Market cap 3-year change

    +144.75%
    EWTX market capitalization is up +144.75% over the past 3 years

    Market cap All-time high

    $3.47B
    EWTX market capitalization is currently -57.28% below its historical high of $3.47 billion

    Market cap sector rank

    77.27%
    EWTX market capitalization is higher than 77.27% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +12.34%
    EWTX shares outstanding is up +12.34% year-on-year

    Shares Outstanding 3-Year Change

    +66.81%
    EWTX shares outstanding is up +66.81% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.36
    EWTX beta is 1.36

    200-day SMA

    $19.75
    EWTX price is currently -28.83% below its 200-day simple moving average

    50-day SMA

    $14.06
    EWTX price is currently +0.01% above its 50-day simple moving average

    RSI

    46.83
    EWTX 14-day relative strength index is 46.83

    Volume

    1.06
    EWTX 30-day relative volume is 1.06

    ATR

    $0.68
    EWTX average true range is $0.68

    10-day Historical Volatility

    50.90%
    EWTX 10-day historical volatility is 50.90%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    EWTX annual revenue is $0.00

    Revenue Analysts estimate

    -
    EWTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    EWTX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    EWTX annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$1.45
    EWTX annual earnings per share is -$1.45

    EPS Analysts estimate

    -$1.62
    EWTX annual earnings per share is currently -10.37% lower than the consensus analysts' forecast

    EPS 1-year change

    +7.64%
    EWTX annual earnings per share is up +7.64% year-on-year

    EPS Sector rank

    43.74%
    EWTX annual earnings per share is higher than 43.74% of companies in Healthcare sector

    Profit

    Gross profit

    -$2.29M
    EWTX annual gross profit is -$2.29 million

    Gross margin

    -
    EWTX annual gross profit margin value is unknown

    Operating profit

    -$158.83M
    EWTX annual operating income is -$158.83 million

    Operating margin

    -
    EWTX annual operating profit margin value is unknown

    Net income

    -$133.81M
    EWTX annual net profit is -$133.81 million

    Net margin

    -
    EWTX annual net profit margin value is unknown

    Expenses

    Total expenses

    $158.83M
    EWTX annual total expenses is $158.83 million

    Operating expenses

    $158.83M
    EWTX annual total operating expenses is $158.83 million

    Cost of goods sold

    $2.29M
    EWTX annual cost of goods sold is $2.29 million

    Selling, general & administrative expenses

    $31.87M
    EWTX annual SGA is $31.87 million

    Depreciation and amortization

    $2.29M
    EWTX annual depreciation & amortization is $2.29 million

    Interest expense

    $0.00
    EWTX annual interest expense is $0.00

    Income tax

    $0.00
    EWTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$158.83M
    EWTX annual earnings before interest & taxes is -$158.83 million

    EBITDA

    -$156.54M
    EWTX annual EBITDA is -$156.54 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $486.82M
    EWTX annual total assets is $486.82 million

    Non current assets

    $11.33M
    EWTX annual long term assets is $11.33 million

    Current assets

    $475.48M
    EWTX annual total current assets is $475.48 million

    Cash and cash equivalents

    $41.67M
    EWTX annual cash & cash equivalents is $41.67 million

    Accounts receivable

    -
    EWTX annual accounts receivable value is unknown

    Inventory

    $0.00
    EWTX annual inventory is $0.00

    Liabilities

    Total liabilities

    $27.60M
    EWTX annual total liabilities is $27.60 million

    Long term liabilities

    $3.74M
    EWTX annual total long term liabilities is $3.74 million

    Current liabilities

    $23.86M
    EWTX annual total current liabilities is $23.86 million

    Accounts payable

    $5.58M
    EWTX annual accounts payable is $5.58 million

    Debt

    Total debt

    $4.74M
    EWTX annual total debt is $4.74 million

    Total debt 1-year change

    -12.5%
    EWTX annual total debt is down -12.5% year-on-year

    Long term debt

    $3.74M
    EWTX annual long term debt is $3.74 million

    Short term debt

    $996.00K
    EWTX annual short term debt is $996.00 thousand

    Equity & Capital

    Shareholders equity

    $459.22M
    EWTX annual stockholders equity is $459.22 million

    Book value

    $459.22M
    EWTX annual book value is $459.22 million

    Retained earnings

    -$378.58M
    EWTX annual retained earnings is -$378.58 million

    Working capital

    $451.62M
    EWTX annual working capital is $451.62 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$109.03M
    EWTX annual cash flow from operations is -$109.03 million

    Cash from operations 1-year change

    -18.58%
    EWTX annual cash flow from operations is down -18.58% year-on-year

    Cash from investing

    -$184.66M
    EWTX annual cash flow from investing activities is -$184.66 million

    Cash from investing 1-year change

    -279.48%
    EWTX annual cash flow from investing activities is down -279.48% year-on-year

    Cash from financing

    $249.25M
    EWTX annual cash flow from financing activities is $249.25 million

    Cash from financing 1-year change

    +368.82%
    EWTX annual cash flow from financing activities is up +368.82% year-on-year

    CAPEX

    CAPEX

    $1.31M
    EWTX annual capital expenditures is $1.31 million

    CAPEX 1-year change

    -77.16%
    EWTX annual capital expenditures is down -77.16% year-on-year

    Free Cash Flow

    Free cash flow

    -$110.34M
    EWTX annual free cash flow is -$110.34 million

    Free cash flow 1-year change

    -12.95%
    EWTX annual free cash flow is down -12.95% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    EWTX annual gross profit margin value is unknown

    Operating margin

    -
    EWTX annual operating profit margin value is unknown

    Net margin

    -
    EWTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -32.37%
    EWTX annual return on assets is -32.37%

    ROE

    -34.40%
    EWTX annual return on equity is -34.40%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    EWTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    EWTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.51
    EWTX price to book ratio is 2.51

    PB ratio Sector rank

    60.02%
    EWTX price to book ratio is higher than 60.02% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    EWTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    EWTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $891.54M
    EWTX enterprise value is $891.54 million

    Enterprise value Sector rank

    72.17%
    EWTX enterprise value is higher than 72.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.18
    EWTX EV/EBITDA is -5.18

    EV/EBITDA Sector rank

    22.24%
    EWTX EV/EBITDA is higher than 22.24% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    19.93
    EWTX annual current ratio is 19.93

    Quick ratio

    19.93
    EWTX annual quick ratio is 19.93

    Leverage

    Debt to equity

    0.01
    EWTX annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    EWTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    EWTX piotroski f-score value is unknown

    Altman Z-Score

    31.15
    EWTX altman z-score is 31.15

    Analyst ratings

    Recent major analysts updates

    Aug 19, 25 JP Morgan
    Overweight
    Aug 8, 25 RBC Capital
    Outperform
    Jun 30, 25 HC Wainwright & Co.
    Buy
    Jun 5, 25 RBC Capital
    Outperform
    May 16, 25 JP Morgan
    Overweight
    May 9, 25 RBC Capital
    Outperform
    Apr 21, 25 Wedbush
    Outperform
    Apr 3, 25 Scotiabank
    Sector Perform
    Apr 3, 25 RBC Capital
    Outperform
    Apr 2, 25 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with EWTX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Edgewise Therapeutics, Inc.?
    • Does Edgewise Therapeutics, Inc. pay dividends?
    • What sector is Edgewise Therapeutics, Inc. in?
    • What industry is Edgewise Therapeutics, Inc. in?
    • What country is Edgewise Therapeutics, Inc. based in?
    • When did Edgewise Therapeutics, Inc. go public?
    • Is Edgewise Therapeutics, Inc. in the S&P 500?
    • Is Edgewise Therapeutics, Inc. in the NASDAQ 100?
    • Is Edgewise Therapeutics, Inc. in the Dow Jones?
    • When was Edgewise Therapeutics, Inc.'s last earnings report?
    • When does Edgewise Therapeutics, Inc. report earnings?

    What is the ticker symbol for Edgewise Therapeutics, Inc.?

    The ticker symbol for Edgewise Therapeutics, Inc. is NASDAQ:EWTX

    Does Edgewise Therapeutics, Inc. pay dividends?

    No, Edgewise Therapeutics, Inc. does not pay dividends

    What sector is Edgewise Therapeutics, Inc. in?

    Edgewise Therapeutics, Inc. is in the Healthcare sector

    What industry is Edgewise Therapeutics, Inc. in?

    Edgewise Therapeutics, Inc. is in the Biotechnology industry

    What country is Edgewise Therapeutics, Inc. based in?

    Edgewise Therapeutics, Inc. is headquartered in United States

    When did Edgewise Therapeutics, Inc. go public?

    Edgewise Therapeutics, Inc.'s initial public offering (IPO) was on March 26, 2021

    Is Edgewise Therapeutics, Inc. in the S&P 500?

    No, Edgewise Therapeutics, Inc. is not included in the S&P 500 index

    Is Edgewise Therapeutics, Inc. in the NASDAQ 100?

    No, Edgewise Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Edgewise Therapeutics, Inc. in the Dow Jones?

    No, Edgewise Therapeutics, Inc. is not included in the Dow Jones index

    When was Edgewise Therapeutics, Inc.'s last earnings report?

    Edgewise Therapeutics, Inc.'s most recent earnings report was on May 8, 2025

    When does Edgewise Therapeutics, Inc. report earnings?

    The next expected earnings date for Edgewise Therapeutics, Inc. is November 6, 2025
    On this page